Super MIC's clinical depth comes from the convergence of three distinct functional clusters that collectively address fat metabolism from mobilization through oxidation through energy production — with neurochemical and appetite-regulatory support woven throughout:

The lipotropic core (methionine + inositol + choline) optimizes hepatic fat processing: All three lipotropic agents support phosphatidylcholine synthesis and hepatic lipid export through complementary pathways — methionine via SAMe and the methylation pathway, choline as a direct phosphatidylcholine precursor, inositol as a phosphatidylinositol component and insulin sensitizer. Together they ensure the liver can efficiently process and export dietary and mobilized triglycerides rather than accumulating them as hepatic fat, while inositol's insulin sensitization supports the hormonal environment in which fat mobilization is most effectively achieved.

The mitochondrial transport engine (L-carnitine) converts mobilized fat to energy: Lipotropic activity in the liver and insulin-mediated fat mobilization from adipose tissue only produce body composition benefit if the mobilized fatty acids successfully enter mitochondria for oxidation. L-carnitine — at the formula's highest concentration — ensures this transport step is not the rate-limiting factor in fat oxidation, maximizing the conversion of mobilized fat stores to cellular energy and reducing the energy deficits that drive fatigue and compensatory appetite increases.

The B vitamin infrastructure (cyanocobalamin + thiamine + pyridoxine) powers and regulates the entire process: The citric acid cycle reactions that convert fatty acids, glucose, and amino acids to ATP require B vitamin cofactors at multiple enzymatic steps simultaneously. Thiamine gates pyruvate entry into the cycle. B12 supports the methionine cycle that underpins lipotropic activity.

Pyridoxine enables the amino acid metabolism and neurotransmitter synthesis that regulate appetite, mood, and the behavioral sustainability of weight management. Together they ensure that the metabolic machinery processing fat into energy is fully supported — and that the neurochemical environment supporting appetite regulation and mood is maintained throughout the weight loss process.

With consistent once-to-twice-weekly administration as part of a provider-supervised weight management protocol:

Support for hepatic lipid processing and prevention of abnormal liver fat accumulation through the lipotropic MIC complex

Improved fat mobilization and utilization through enhanced insulin sensitivity (inositol) and optimized hepatic lipid export (methionine + choline)

Enhanced fat oxidation and conversion to cellular energy through L-carnitine's mitochondrial fatty acid transport activity

Improved energy levels and reduced fatigue through B vitamin-supported ATP production and mitochondrial efficiency

Appetite regulation and mood support through inositol and pyridoxine's neurochemical pathway activity

Cholesterol management support through lipotropic regulation of hepatic lipid metabolism

Support for neurotransmitter synthesis — serotonin, dopamine, acetylcholine, GABA — relevant to appetite, mood, and the behavioral dimensions of sustained weight management

Improved exercise performance, muscle recovery, and physical endurance through L-carnitine's fatty acid oxidation support

Optimized oxygen delivery and red blood cell function through B12 support of erythropoiesis

Enhanced absorption reliability compared to oral lipotropic supplementation through direct injectable delivery to systemic circulation

Comprehensive metabolic support that addresses fat metabolism from liver processing through mitochondrial oxidation through energy production in a single weekly or biweekly injection

Results vary by individual, baseline nutritional status, dietary adherence, activity level, and concurrent weight management interventions. Super MIC is a metabolic support tool — it is most effective as part of a comprehensive weight management program that includes appropriate caloric management and physical activity. It is not a standalone weight loss treatment.

Inject 1 mL intramuscularly (IM) or subcutaneously (SC) once to twice weekly, as directed by your prescribing provider.

Intramuscular administration sites: Deltoid (upper arm), vastus lateralis (outer thigh), or ventrogluteal muscle. IM injection delivers the formula directly into muscle tissue for reliable absorption and relatively rapid distribution.

Subcutaneous administration sites: Abdomen (at least 2 inches from the navel), outer thigh, or upper arm. SC injection is generally more comfortable and easier for self-administration; absorption is slightly slower than IM but clinically equivalent for this formulation.

General injection technique:

Wash hands thoroughly. Prepare the injection site with an alcohol swab and allow to dry.

Draw 1 mL from the vial using a sterile syringe and appropriate gauge needle.

Inspect the solution before drawing — it should be clear to slightly colored. Do not use if particulate matter, cloudiness, or unusual discoloration is present.

Administer via your prescribed route. Rotate injection sites with each administration to prevent tissue irritation from repeated injection at the same location.

Apply gentle pressure to the injection site with a clean swab after administration. Do not massage vigorously.

Dispose of used needles and syringes immediately in a sharps container. Never reuse needles or syringes.

Frequency: Once weekly is a standard starting frequency. Twice weekly may be prescribed for patients with higher metabolic support goals or those in more intensive weight management protocols. Follow your provider's specific instructions.

If a dose is missed: Administer when remembered if it is not too close to the next scheduled injection. Do not double-dose. Resume your regular schedule at the next planned administration.

Super MIC Injection is a prescription-only compounded injectable medication. Full patient counseling and clinical assessment are required before initiating therapy.

Contraindications:

Known hypersensitivity: Patients with documented allergy to any component — methionine, inositol, choline, cyanocobalamin (including cobalt allergy), L-carnitine, thiamine, or pyridoxine — should not use this product.

Leber's hereditary optic neuropathy: Cyanocobalamin is contraindicated in patients with Leber's disease — it can precipitate or accelerate optic nerve atrophy in this condition. Patients with this diagnosis must use an alternative B12 formulation (hydroxocobalamin or methylcobalamin) and must inform their provider.

Severe renal impairment: L-carnitine and several B vitamins are renally excreted. Patients with significant renal impairment should discuss dose appropriateness with their provider before initiating.

Seizure disorders: High-dose pyridoxine has paradoxically been associated with peripheral neuropathy and, in rare cases, with alterations in seizure threshold at very high chronic doses. Patients with seizure disorders should discuss this formula with their neurologist.

Pregnancy and breastfeeding: While individual components of this formula are present in prenatal vitamins and generally considered safe, the combination at injectable concentrations during pregnancy and lactation has not been specifically studied. Discuss with your provider before initiating or continuing during pregnancy.

Potential Side Effects:

Injection site reactions (most common):

Pain, tenderness, or mild swelling at the injection site — more common with IM than SC administration; typically resolves within 24–48 hours

Erythema or mild bruising at the injection site — manage with site rotation and appropriate injection technique

Rare injection site nodule formation with repeated SC injection at the same site — prevented by consistent site rotation

Systemic — generally mild and uncommon:

Mild nausea or GI discomfort — reported by some patients, particularly after initial injections; typically resolves with continued use

Urinary odor changes — methionine metabolism can produce sulfur-containing metabolites that alter urine odor; benign and expected

Warm or flushing sensation — may occur with IM injection due to rapid B vitamin absorption; transient and harmless

Mild headache — reported occasionally; typically transient

Unusual urine color — B vitamins, particularly B12 and B2 if present, can produce bright yellow urine coloration; benign

Rare:

Allergic or hypersensitivity reaction — discontinue and seek medical evaluation if urticaria, significant swelling, difficulty breathing, or anaphylactic symptoms develop

Peripheral neuropathy with very high chronic pyridoxine exposure — not expected at doses in this formulation but worth monitoring in patients with pre-existing neuropathy

Rare B12 hypersensitivity reactions — cyanocobalamin-specific sensitivity exists in rare patients; hydroxocobalamin or methylcobalamin may be substituted if needed

Metformin: Metformin is associated with B12 depletion through reduced ileal absorption with chronic use — many patients on metformin benefit from B12 supplementation; cyanocobalamin in this formula may support B12 status in this population.

Other B12-containing supplements or injections: Discuss all concurrent B12 supplementation with your provider to ensure total B12 exposure remains clinically appropriate.

Levodopa: High-dose pyridoxine can reduce the clinical efficacy of levodopa in patients with Parkinson's disease by enhancing its peripheral metabolism. Patients on levodopa should inform their provider before initiating pyridoxine-containing injectables.

Oral contraceptives and estrogen therapy: Estrogen-containing medications can increase the metabolic demand for pyridoxine and B12; concurrent use with Super MIC may be beneficial but should be coordinated with the prescribing provider.

Anticonvulsants: Several anticonvulsant medications (phenytoin, carbamazepine, valproate) deplete B vitamins and interact with folate and B12 metabolism. Patients on anticonvulsants should discuss B vitamin supplementation with their neurologist.

Thyroid medications: L-carnitine has been shown to antagonize thyroid hormone action at the cellular level in some research contexts; patients on thyroid medication should inform their provider of L-carnitine use.

Warfarin: Both cyanocobalamin and thiamine have theoretical interactions with coagulation; patients on anticoagulant therapy should inform their provider.

Refrigerate at 36°F – 46°F (2°C – 8°C)

Do not freeze

Protect from light — store in original packaging or a light-protected container

Keep container tightly sealed between uses

Beyond use date: 90 days from compounding date as labeled

Inspect solution before each use — discard if cloudy, particulate, or discolored beyond expected coloration

Keep out of reach of children

For single patient use only — do not share vials between patients